Abstract:
Some species of the Orchidaceae family are used in Mexican traditional medicine. However, there are no current and critical compilations of the medicinal uses and pharmacological effects of the members of the Orchidaceae family. This review provides a current, critical, and comprehensive analysis of the traditional medicinal uses, pharmacological reports, and active compounds isolated from Mexican orchids. A total of 62 Mexican orchids with medicinal potential have been recorded, of which 14 have scientific evidence. The remaining 48 plant species have ethnomedicinal information but have not been validated with scientific studies. These orchids are distributed in 14 states of the Mexican Republic, mainly in the southern region of Mexico. The most common pharmacological activities reported are anti-inflammatory, vasorelaxant, antinociceptive, antioxidant, spasmolytic, antihypertensive, and hallucinogenic activities. It is necessary to increase the number of pharmacological, phytochemical, and toxicological studies with medicinal orchids from Mexico because there are scientific studies on only 22.5% of these species. In further studies, it will be possible to evaluate the pharmacological effects of Mexican orchids in clinical trials. In addition, the mechanisms of action by which plant extracts and their active compounds exert medicinal effects remain to be studied. Plant extracts from orchids and their active compounds show promising antinociceptive and spasmolytic effects, respectively.
摘要:
兰科的某些物种用于墨西哥传统医学。然而,目前尚无兰科成员的药用用途和药理作用的关键汇编。这篇评论提供了一个当前的,关键,以及对传统药用的综合分析,药理学报告,和从墨西哥兰花中分离出的活性化合物。总共记录了62种具有药用潜力的墨西哥兰花,其中14个有科学证据。其余48种植物具有种族信息,但尚未通过科学研究进行验证。这些兰花分布在墨西哥共和国的14个州,主要在墨西哥南部地区。据报道,最常见的药理活性是抗炎,血管松弛剂,抗伤害性,抗氧化剂,痉挛,抗高血压药,和致幻活动。有必要增加药理学的数量,植物化学,和毒理学研究来自墨西哥的药用兰花,因为只有22.5%的这些物种的科学研究。在进一步的研究中,在临床试验中评估墨西哥兰花的药理作用是可能的。此外,植物提取物及其活性化合物发挥药用作用的机制仍有待研究。兰花及其活性化合物的植物提取物显示出有希望的抗伤害和解痉挛作用,分别。